Lilly and the William Sansum Diabetes Center announce a five-year research collaboration

Eli Lilly and Co.and the William Sansum Diabetes Center have established a research collaboration to improve the lives of Latino people affected by diabetes through enhanced research, education and care.

APEIRON Receives Marketing Approval of a Neuroblastoma Immunotherapy in the EU

APEIRON Biologics AG announced that the EMA Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of dinutuximab beta...

Biotronik launches Edora MR-conditional pacemakers

BIOTRONIK Launches its Smallest and Lightest MR-Conditional Pacemakers and a New Range of Quadripolar CRT-Ps in Europe.Edora Devices Feature MRI AutoDetect, BIOTRONIK Home Monitoring and Unique Physiological Rate Adaptation for Enhanced.

PGDx Announces Expanded Cancer Testing Contract with US Department of Veteran Affairs

Personal Genome Diagnostics Inc announced an expansion of its cancer testing contract with the U.S. Department of Veterans Affairs that replaces an earlier tumor profiling assay with the company new CancerSELECT 125 test.

PromarkerD Predictive Diagnostics for DKD to Roll-out in Asia

Proteomics International Laboratories,the leader in predictive diagnostics for diabetic kidney disease, will advance deals with commercialisation partners in Singapore and China this week to bring PromarkerD, which is patented in both countries to the Asian Market.

Aegis Medical Innovations Announces FDA Approval of Clinical Trial

Aegis Medical Innovations Inc announced that it has received Investigational Device Exemption approval from the U.S. FDA to initiate a clinical trial in the U.S. for its medical device called the Sierra Ligation System (Sierra).